Vejle Sygehus, Sygehus Lillebælt, er et mellemstort sygehus beliggende i Vejle. Det har siden Strukturreformen 2007 været drevet af Region Syddanmark og hørte inden da under Vejle Amt. Sygehuset ligger op mod den nordlige bakkekam ved Vejle Centrum og kan ses fra næsten hele byen.

During the past decade, Department of Oncology, Vejle Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 5 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Oncology, Vejle Hospital" #1 sponsor was "Vejle Hospital" with 20 trials, followed by "Hoffmann-La Roche" with 7 trials sponsored, "Genentech, Inc." with 2 trials sponsored, "Odense University Hospital" with 2 trials sponsored and "Olfred Hansen" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Oncology, Vejle Hospital" #1 collaborator was "Aalborg University Hospital" with 3 trials as a collaborator, "Aarhus University Hospital" with 3 trials as a collaborator, "Danish Cancer Society" with 3 trials as a collaborator, "Rigshospitalet, Denmark" with 3 trials as a collaborator and "Abbott" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Department of Oncology, Vejle Hospital" are "Breast Cancer" (6 trials), "Ovarian Cancer" (5 trials), "Colorectal Cancer" (2 trials), "Colorectal Cancer Metastatic" (2 trials) and "Non-small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Department of Oncology, Vejle Hospital" in a lesser frequency.

Most popular intervention types in "Department of Oncology, Vejle Hospital" are "Drug" (27 trials), "Dietary Supplement" (4 trials), "Radiation" (4 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Trastuzumab" (5 trials), "Bevacizumab" (4 trials), "Capecitabine" (4 trials) and "Atezolizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Department of Oncology, Vejle Hospital" are 24 trials for "All" genders and 10 trials for "Female" genders.

Currently, there are NaN active trials in "Department of Oncology, Vejle Hospital". undefined are not yet recruiting, 8 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Department of Oncology, Vejle Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Oncology, Vejle Hospital, 3 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".